Autophagy/Apoptosis Balance During Pregnancy

Launched by CENTRE HOSPITALIER UNIVERSITAIRE DE NĪMES · Jun 19, 2020

Keywords

ClinConnect Summary

This clinical trial, titled "Autophagy/Apoptosis Balance During Pregnancy," is studying how certain processes in the body that help cells survive or die (called autophagy and apoptosis) work during pregnancy. Researchers want to see how these processes differ among women who have normal pregnancies and those who might be at higher risk for complications. They believe that the balance between these two processes is important for the health of the pregnancy and that changes in this balance could lead to problems.

To participate in this study, women must be under 33 weeks pregnant and planning to give birth at the CHU Nîmes hospital. They need to provide consent to join the study and must have health insurance. Participants will be closely monitored during their pregnancy to understand how autophagy and apoptosis interact. This research could help improve care for pregnant women, especially those at risk of complications. If you have questions or want to know more about getting involved, it’s best to reach out to the study team.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Patients followed at the CHU Nîmes prior to 33 weeks gestation who give birth at the hospital
• • The patient must have given their free and informed consent and signed the consent form
• • The patient must be a member or beneficiary of a health insurance plan
• Exclusion Criteria:
• • The subject is participating in a category 1 interventional study associated with a medication, or is in a period of exclusion determined by a previous study
• • The subject refuses to sign the consent
• • It is impossible to give the subject informed information
• • The patient is under safeguard of justice or state guardianship
• • Multiple pregnancy